Latest Strategic Funding News

Paradigm Biopharmaceuticals has secured a $6.3 million R&D Tax Incentive refund, lifting its cash reserves to $31 million and reinforcing its push into Phase 3 osteoarthritis clinical trials.

Australian Silica Quartz Group reports promising gold intersections at Koolyanobbing Metals Project and progresses its Quartz Hill silica project with positive metallurgical results and strategic funding.

Icetana Limited reports a sharp decline in cash flow for the December quarter, offset by plans for an underwritten rights issue to bolster funding and expectations of improved customer receipts in coming quarters.

Arafura Rare Earths has locked in a A$200 million convertible note investment from the National Reconstruction Fund Corporation, marking a pivotal step toward developing Australia's first ore-to-oxide rare earths processing operation at Nolans.